In response to the statement issued today by the Organization for Economic Cooperation and Development’s (OECD) Development Assistance Committee, which says that countries will be able to count donations of unwanted vaccine doses as part of their foreign aid commitment, for a guideline cost of $6.72 a dose, Oxfam’s Health Policy Manager, Anna Marriott, said:
“This guidance is a double insult to the world’s poorest countries. Firstly, rich countries bought up many more doses than they could use at a time of limited supply, preventing millions of people in developing countries from getting life-saving vaccines. Now they are free to charge any donations of unwanted doses to their aid budgets, to the detriment of other essential aid spending.
“Rich countries should donate any excess doses immediately to developing countries, but this should not be at the expense of aid countries desperately need to help save lives. It is not only immoral, but there’s a high chance of failure if the donations replace aid that would have supported health systems and other non-vaccine related costs that are critical for their delivery, especially at a time when COVAX has run out of funds.
“Due to the lack of safeguards in this guidance, rich countries could count donated vaccines as aid that can never reach arms, because they are donated too close to expiry or without essential equipment such as syringes. Between them, G7 countries currently have over 240 million doses which are due to expire at the end of February.
“Many of the same rich country governments that this guidance applies to are also those continuing to block proposals to enable and encourage the widescale generic production of COVID-19 vaccines in developing countries ―measures that would scale up vaccine access, drive down prices and diminish the need for donations in the first place.
“If generic production of vaccines were allowed, each $6.72 of aid could purchase five vaccine doses, instead of just one.”
Notes to editors
In a recent statement, Oxfam joined with more than 30 organizations around the world to call for the plan to count donated excess COVID-19 vaccines as aid to be scrapped following failure of OECD DAC members to agree.
According to Airfinity data, G7 countries have 241 million doses of COVID-19 vaccines which will expire in March 2022.
Experts have estimated that the Pfizer vaccine could be produced for as little as $1.18 a dose.
Contact information
Sarah Dransfield in the UK | SDransfield@oxfam.org.uk | +44 (0)7884 114825
Jade Tenwick in Brussels, Belgium | jade.tenwick@oxfam.org | +32 (0) 473 56 22 60
For updates, please follow @NewsFromOxfam and @Oxfam
In a recent statement, Oxfam joined with more than 30 organizations around the world to call for the plan to count donated excess COVID-19 vaccines as aid to be scrapped following failure of OECD DAC members to agree.
According to Airfinity data, G7 countries have 241 million doses of COVID-19 vaccines which will expire in March 2022.
Experts have estimated that the Pfizer vaccine could be produced for as little as $1.18 a dose.
Sarah Dransfield in the UK | SDransfield@oxfam.org.uk | +44 (0)7884 114825
Jade Tenwick in Brussels, Belgium | jade.tenwick@oxfam.org | +32 (0) 473 56 22 60
For updates, please follow @NewsFromOxfam and @Oxfam